Compare Invesco DB Agriculture Fund (DBA) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco DB Agriculture Fund vs DexCom, Inc. — how do they compare? Invesco DB Agriculture Fund trades at $27.74, while DexCom, Inc. trades at $89 (market cap $33.79B). The key difference: DexCom, Inc. is trading nearer its 52-week high, Invesco DB Agriculture Fund nearer its low. Which is the better fit depends on your goals.
| DBA | DXCM | |
|---|---|---|
52-Week High | $28.73 | $89.53 |
52-Week Low | $25.44 | $54.84 |
Market Cap | — | $33.79B |
Sector | — | Health |
Enterprise Value | — | $33.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DBA trades at $27.69, down 0.47% today, but maintains a strong technical bullish signal with moving averages indicating positive momentum. The fund has outperformed the S&P 500 recently, gaining 5% in July 2026, driven by strength in agricultural commodities. It consolidates near highs with a bullish trend established since 2020, supported by a 3.25% yield.
The outlook remains positive given favorable agricultural market dynamics and geopolitical factors supporting commodity prices. Key risks include sector volatility, management fees, and sensitivity to global crop conditions and trade policies. The fund offers diversified exposure to agricultural futures as a hedge against inflation and supply disruptions.
DexCom (DXCM) trades at $87.65, up 3.42% today and near its 52-week high, with a bullish technical signal from moving averages and strong fundamental performance. Revenue grew to $4.66B in 2025, with net income reaching $836.30M and a 20.12% net margin. Recent Q2 2026 earnings beat expectations with $0.70 EPS, and the company raised full-year guidance, reflecting robust demand for its continuous glucose monitoring systems.
The outlook remains positive given consistent earnings beats, margin expansion, and analyst consensus favoring a buy rating with a $88.65 price target. Key risks include competitive pressures in medical devices and potential regulatory scrutiny, but growth drivers like G7 adoption and international expansion support upside potential for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Invesco DB Agriculture Fund
The index, which is comprised of one or more underlying commodities ("index commodities"), is intended to reflect the agricultural sector. The fund pursues its investment objective by investing in a portfolio of exchange-traded futures.
Read more on DBA →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
